Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0240 Transporter Info | ||||
Gene Name | SLC27A3 | ||||
Transporter Name | Long-chain fatty acid transport protein 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Prostate cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
5'UTR (cg12662091) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:3.76E-02; Z-score:1.97E+00 | ||
Methylation in Case |
9.53E-02 (Median) | Methylation in Control | 8.04E-02 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
TSS1500 (cg17243364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.28E+00 | Statistic Test | p-value:9.03E-03; Z-score:-3.15E+00 | ||
Methylation in Case |
1.30E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
TSS1500 (cg13818276) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:3.03E-02; Z-score:3.35E+00 | ||
Methylation in Case |
8.39E-01 (Median) | Methylation in Control | 7.27E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
Body (cg19377250) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.52E+00 | Statistic Test | p-value:1.88E-03; Z-score:6.25E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 5.41E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
Body (cg11640015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.24E+00 | Statistic Test | p-value:5.34E-03; Z-score:2.32E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 6.61E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:3.16E-03; Z-score:2.42E+00 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 5.80E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:2.33E-02; Z-score:1.08E+00 | ||
Methylation in Case |
6.79E-01 (Median) | Methylation in Control | 6.30E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg05784314) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.37E+00 | Statistic Test | p-value:2.93E-02; Z-score:1.62E+00 | ||
Methylation in Case |
4.46E-02 (Median) | Methylation in Control | 3.27E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.69E+00 | Statistic Test | p-value:3.53E-02; Z-score:-3.27E+00 | ||
Methylation in Case |
1.40E-01 (Median) | Methylation in Control | 2.38E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
3'UTR (cg11804721) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:5.00E-06; Z-score:-1.21E+01 | ||
Methylation in Case |
4.27E-01 (Median) | Methylation in Control | 5.52E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.62E+00 | Statistic Test | p-value:7.34E-32; Z-score:4.88E+00 | ||
Methylation in Case |
6.60E-01 (Median) | Methylation in Control | 4.08E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg03138446) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:2.88E-18; Z-score:2.54E+00 | ||
Methylation in Case |
8.04E-01 (Median) | Methylation in Control | 6.55E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.56E+00 | Statistic Test | p-value:8.78E-15; Z-score:3.13E+00 | ||
Methylation in Case |
6.74E-01 (Median) | Methylation in Control | 4.33E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.68E+00 | Statistic Test | p-value:1.25E-09; Z-score:2.90E+00 | ||
Methylation in Case |
2.33E-01 (Median) | Methylation in Control | 1.39E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg24408896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.43E+00 | Statistic Test | p-value:1.01E-07; Z-score:1.46E+00 | ||
Methylation in Case |
1.49E-01 (Median) | Methylation in Control | 1.04E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.68E+00 | Statistic Test | p-value:1.40E-07; Z-score:2.30E+00 | ||
Methylation in Case |
2.70E-01 (Median) | Methylation in Control | 1.61E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg06239526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.59E+00 | Statistic Test | p-value:3.10E-06; Z-score:1.56E+00 | ||
Methylation in Case |
1.50E-01 (Median) | Methylation in Control | 9.43E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg16247817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.65E+00 | Statistic Test | p-value:6.24E-06; Z-score:1.41E+00 | ||
Methylation in Case |
5.43E-02 (Median) | Methylation in Control | 3.28E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg05784314) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.44E+00 | Statistic Test | p-value:3.42E-02; Z-score:3.65E-01 | ||
Methylation in Case |
4.21E-02 (Median) | Methylation in Control | 2.92E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
Body (cg15930240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.24E+00 | Statistic Test | p-value:5.67E-09; Z-score:1.84E+00 | ||
Methylation in Case |
7.00E-01 (Median) | Methylation in Control | 5.63E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.64E+00 | Statistic Test | p-value:4.48E-05; Z-score:1.13E+00 | ||
Methylation in Case |
1.92E-01 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:9.50E-03; Z-score:7.34E-01 | ||
Methylation in Case |
7.80E-01 (Median) | Methylation in Control | 7.56E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.86E+00 | Statistic Test | p-value:5.43E-06; Z-score:1.46E+00 | ||
Methylation in Case |
2.61E-01 (Median) | Methylation in Control | 1.40E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg24408896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.93E+00 | Statistic Test | p-value:3.40E-04; Z-score:1.03E+00 | ||
Methylation in Case |
1.56E-01 (Median) | Methylation in Control | 8.08E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg03138446) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.01E-02; Z-score:-4.39E-01 | ||
Methylation in Case |
9.33E-01 (Median) | Methylation in Control | 9.41E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
1stExon (cg06089988) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:5.34E-05; Z-score:1.54E+00 | ||
Methylation in Case |
9.60E-02 (Median) | Methylation in Control | 7.86E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
1stExon (cg07246449) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:1.60E-04; Z-score:1.19E+00 | ||
Methylation in Case |
8.15E-02 (Median) | Methylation in Control | 7.10E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
1stExon (cg23376526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:9.81E-04; Z-score:1.15E+00 | ||
Methylation in Case |
9.70E-02 (Median) | Methylation in Control | 8.10E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
3'UTR (cg11804721) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:1.58E-03; Z-score:-1.07E+00 | ||
Methylation in Case |
6.35E-01 (Median) | Methylation in Control | 7.21E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg03138446) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:5.17E-08; Z-score:-1.17E+00 | ||
Methylation in Case |
8.26E-01 (Median) | Methylation in Control | 8.49E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:2.02E-07; Z-score:1.50E+00 | ||
Methylation in Case |
7.77E-01 (Median) | Methylation in Control | 7.12E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:1.04E-06; Z-score:-1.26E+00 | ||
Methylation in Case |
1.55E-01 (Median) | Methylation in Control | 2.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.16E-05; Z-score:-1.10E+00 | ||
Methylation in Case |
7.09E-01 (Median) | Methylation in Control | 7.38E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.45E+00 | Statistic Test | p-value:1.22E-08; Z-score:-1.36E+00 | ||
Methylation in Case |
1.95E-01 (Median) | Methylation in Control | 2.82E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg06239526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.66E+00 | Statistic Test | p-value:1.21E-06; Z-score:-1.22E+00 | ||
Methylation in Case |
1.11E-01 (Median) | Methylation in Control | 1.85E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg24408896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:9.56E-04; Z-score:-7.91E-01 | ||
Methylation in Case |
1.29E-01 (Median) | Methylation in Control | 1.69E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg16247817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.36E+00 | Statistic Test | p-value:1.39E-02; Z-score:-6.80E-01 | ||
Methylation in Case |
5.53E-02 (Median) | Methylation in Control | 7.50E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg01841415) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:2.09E-18; Z-score:-5.43E+00 | ||
Methylation in Case |
4.81E-01 (Median) | Methylation in Control | 6.93E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg03364832) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.74E+00 | Statistic Test | p-value:4.31E-18; Z-score:-3.80E+00 | ||
Methylation in Case |
3.79E-01 (Median) | Methylation in Control | 6.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg22985016) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.94E+00 | Statistic Test | p-value:1.53E-17; Z-score:-2.95E+00 | ||
Methylation in Case |
3.69E-01 (Median) | Methylation in Control | 7.17E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg25368728) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.41E+00 | Statistic Test | p-value:2.88E-14; Z-score:-2.92E+00 | ||
Methylation in Case |
5.11E-01 (Median) | Methylation in Control | 7.20E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg00502885) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.39E+00 | Statistic Test | p-value:1.33E-11; Z-score:-4.09E+00 | ||
Methylation in Case |
5.66E-01 (Median) | Methylation in Control | 7.84E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg23701033) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.35E+00 | Statistic Test | p-value:6.16E-10; Z-score:-1.88E+00 | ||
Methylation in Case |
3.67E-01 (Median) | Methylation in Control | 4.94E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
3'UTR (cg16392193) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.51E+00 | Statistic Test | p-value:1.92E-17; Z-score:-3.83E+00 | ||
Methylation in Case |
2.72E-01 (Median) | Methylation in Control | 4.12E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:2.82E-04; Z-score:2.10E+00 | ||
Methylation in Case |
7.08E-01 (Median) | Methylation in Control | 6.08E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.34E+00 | Statistic Test | p-value:3.82E-03; Z-score:2.53E+00 | ||
Methylation in Case |
3.74E-01 (Median) | Methylation in Control | 2.78E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.36E-02; Z-score:1.01E+00 | ||
Methylation in Case |
7.88E-01 (Median) | Methylation in Control | 7.58E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg16247817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.55E+00 | Statistic Test | p-value:4.21E-05; Z-score:2.50E+00 | ||
Methylation in Case |
1.39E-01 (Median) | Methylation in Control | 8.95E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg24408896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.42E+00 | Statistic Test | p-value:4.27E-03; Z-score:2.26E+00 | ||
Methylation in Case |
3.28E-01 (Median) | Methylation in Control | 2.31E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:5.20E-03; Z-score:1.59E+00 | ||
Methylation in Case |
4.11E-01 (Median) | Methylation in Control | 3.27E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg06239526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:5.30E-03; Z-score:1.60E+00 | ||
Methylation in Case |
3.16E-01 (Median) | Methylation in Control | 2.37E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg05784314) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:2.90E-02; Z-score:2.64E+00 | ||
Methylation in Case |
1.00E-01 (Median) | Methylation in Control | 7.82E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg15930240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:4.50E-02; Z-score:2.87E+00 | ||
Methylation in Case |
7.85E-01 (Median) | Methylation in Control | 7.02E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg07748193) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.44E-02; Z-score:-4.65E-01 | ||
Methylation in Case |
5.59E-01 (Median) | Methylation in Control | 5.69E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg04590638) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:3.81E-28; Z-score:-3.74E+00 | ||
Methylation in Case |
5.47E-01 (Median) | Methylation in Control | 7.16E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg15164708) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.25E+00 | Statistic Test | p-value:3.87E-23; Z-score:3.18E+00 | ||
Methylation in Case |
5.08E-01 (Median) | Methylation in Control | 4.06E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg04310063) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:2.48E-11; Z-score:-1.55E+00 | ||
Methylation in Case |
7.18E-01 (Median) | Methylation in Control | 7.82E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg07566700) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:5.04E-10; Z-score:-1.56E+00 | ||
Methylation in Case |
7.56E-01 (Median) | Methylation in Control | 8.19E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg14673267) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:1.46E-02; Z-score:5.31E-01 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 8.82E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg07562926) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:2.74E-02; Z-score:4.75E-01 | ||
Methylation in Case |
7.37E-01 (Median) | Methylation in Control | 7.22E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in panic disorder | [ 9 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-8.99E-01 | Statistic Test | p-value:7.80E-03; Z-score:-3.70E-01 | ||
Methylation in Case |
-1.66E+00 (Median) | Methylation in Control | -1.49E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg03138446) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.10E-11; Z-score:1.50E+00 | ||
Methylation in Case |
8.70E-01 (Median) | Methylation in Control | 8.22E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:4.53E-07; Z-score:1.34E+00 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 7.08E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:4.44E-03; Z-score:6.68E-01 | ||
Methylation in Case |
1.70E-01 (Median) | Methylation in Control | 1.38E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:9.40E-03; Z-score:7.45E-01 | ||
Methylation in Case |
8.00E-01 (Median) | Methylation in Control | 7.65E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.37E+00 | Statistic Test | p-value:1.75E-03; Z-score:8.45E-01 | ||
Methylation in Case |
2.01E-01 (Median) | Methylation in Control | 1.47E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS200 (cg06239526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.63E+00 | Statistic Test | p-value:2.14E-03; Z-score:8.60E-01 | ||
Methylation in Case |
1.03E-01 (Median) | Methylation in Control | 6.35E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS200 (cg16247817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:3.28E-02; Z-score:2.20E-01 | ||
Methylation in Case |
8.49E-02 (Median) | Methylation in Control | 8.08E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
1stExon (cg06089988) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:6.74E-03; Z-score:-6.84E-01 | ||
Methylation in Case |
8.25E-02 (Median) | Methylation in Control | 8.84E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
1stExon (cg18163252) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:3.73E-02; Z-score:-2.71E-01 | ||
Methylation in Case |
4.42E-02 (Median) | Methylation in Control | 4.58E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
3'UTR (cg11804721) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.33E+00 | Statistic Test | p-value:3.44E-12; Z-score:-1.92E+00 | ||
Methylation in Case |
4.14E-01 (Median) | Methylation in Control | 5.53E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC27A3 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg23968154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.35E+00 | Statistic Test | p-value:4.37E-06; Z-score:-2.09E+00 | ||
Methylation in Case |
4.94E-01 (Median) | Methylation in Control | 6.65E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC27A3 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg17805836) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:1.98E-05; Z-score:-4.34E+00 | ||
Methylation in Case |
7.82E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC27A3 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg17298751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:8.23E-05; Z-score:1.22E+00 | ||
Methylation in Case |
7.50E-01 (Median) | Methylation in Control | 6.77E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC27A3 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg12082025) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.38E+00 | Statistic Test | p-value:1.45E-03; Z-score:-1.53E+00 | ||
Methylation in Case |
5.71E-01 (Median) | Methylation in Control | 7.87E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.